Use of the CRISPR/Cas9-based epigenetic gene activation system In Vivo: A new potential therapeutic modality.
作者信息
Ibrahim Samar H, Robertson Keith D
机构信息
Division of Pediatric Gastroenterology & Hepatology, Mayo Clinic, Rochester, MN.
Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, MN.
出版信息
Hepatology. 2018 Sep;68(3):1191-1193. doi: 10.1002/hep.29860. Epub 2018 May 14.
Abstract
摘要
相似文献
1
Use of the CRISPR/Cas9-based epigenetic gene activation system In Vivo: A new potential therapeutic modality.基于CRISPR/Cas9的表观遗传基因激活系统在体内的应用：一种新的潜在治疗方式。
Hepatology. 2018 Sep;68(3):1191-1193. doi: 10.1002/hep.29860. Epub 2018 May 14.
2
CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.CRISPR-Cas9 基因编辑：递送方法和治疗潜力。
J Control Release. 2016 Dec 28;244(Pt B):139-148. doi: 10.1016/j.jconrel.2016.08.002. Epub 2016 Aug 4.
3
In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation.通过CRISPR/Cas9介导的反式表观遗传调控实现体内靶基因激活
Cell. 2017 Dec 14;171(7):1495-1507.e15. doi: 10.1016/j.cell.2017.10.025. Epub 2017 Dec 7.
4
Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.CRISPR-Cas9 基因编辑系统的治疗应用传递策略。
J Control Release. 2017 Nov 28;266:17-26. doi: 10.1016/j.jconrel.2017.09.012. Epub 2017 Sep 11.
5
The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.CRISPR/Cas9系统：其递送方式、体内和体外应用以及初创公司的临床开发情况
Biotechnol Prog. 2017 Jul;33(4):1035-1045. doi: 10.1002/btpr.2484. Epub 2017 May 14.
6
CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.基于 CRISPR/Cas9 的基因组编辑在疾病建模和治疗中的应用：非病毒递送的挑战和机遇。
Chem Rev. 2017 Aug 9;117(15):9874-9906. doi: 10.1021/acs.chemrev.6b00799. Epub 2017 Jun 22.
7
In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.用于治疗性基因编辑的CRISPR/Cas9体内递送：进展与挑战
Bioconjug Chem. 2017 Apr 19;28(4):880-884. doi: 10.1021/acs.bioconjchem.7b00057. Epub 2017 Mar 17.
8
The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research.强大的CRISPR/Cas9系统在心血管研究中的潜在应用与挑战。
Int J Cardiol. 2017 Jan 15;227:191-193. doi: 10.1016/j.ijcard.2016.11.177. Epub 2016 Nov 9.
9
Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting.肿瘤来源的外泌体作为 CRISPR/Cas9 的递送平台赋予了癌细胞靶向的组织倾向性。
J Control Release. 2017 Nov 28;266:8-16. doi: 10.1016/j.jconrel.2017.09.013. Epub 2017 Sep 12.
10
Therapeutic applications of CRISPR/Cas9 system in gene therapy.CRISPR/Cas9系统在基因治疗中的治疗应用。
Biotechnol Lett. 2018 Jun;40(6):907-914. doi: 10.1007/s10529-018-2555-y. Epub 2018 Apr 28.
引用本文的文献
1
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes.多功能 CRISPR-Cas9 与工程化免疫沉默的人 T 细胞表位。
Nat Commun. 2019 Apr 23;10(1):1842. doi: 10.1038/s41467-019-09693-x.
本文引用的文献
1
In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation.通过CRISPR/Cas9介导的反式表观遗传调控实现体内靶基因激活
Cell. 2017 Dec 14;171(7):1495-1507.e15. doi: 10.1016/j.cell.2017.10.025. Epub 2017 Dec 7.
2
dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression.基于dCas9的表观基因组编辑表明，组蛋白甲基化的获得不足以抑制靶基因。
Nucleic Acids Res. 2017 Sep 29;45(17):9901-9916. doi: 10.1093/nar/gkx578.
3
CRISPR/Cas9: at the cutting edge of hepatology.CRISPR/Cas9：处于肝病学前沿
Gut. 2017 Jul;66(7):1329-1340. doi: 10.1136/gutjnl-2016-313565. Epub 2017 May 9.
4
CRISPR-Mediated Epigenome Editing.CRISPR介导的表观基因组编辑
Yale J Biol Med. 2016 Dec 23;89(4):471-486. eCollection 2016 Dec.
5
Epigenetics in liver disease: from biology to therapeutics.肝病中的表观遗传学：从生物学到治疗学
Gut. 2016 Nov;65(11):1895-1905. doi: 10.1136/gutjnl-2015-311292. Epub 2016 Sep 13.
6
Nucleosomes impede Cas9 access to DNA in vivo and in vitro.核小体在体内和体外都会阻碍Cas9与DNA的结合。
Elife. 2016 Mar 17;5:e12677. doi: 10.7554/eLife.12677.
7
Epigenetic modifications as new targets for liver disease therapies.表观遗传修饰作为肝脏疾病治疗的新靶点。
J Hepatol. 2013 Dec;59(6):1349-53. doi: 10.1016/j.jhep.2013.05.039. Epub 2013 Jun 4.
8
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.可编程的双 RNA 引导的 DNA 内切酶在适应性细菌免疫中的作用。
Science. 2012 Aug 17;337(6096):816-21. doi: 10.1126/science.1225829. Epub 2012 Jun 28.
Zotero 插件